Skip to main
Rejuvenation Peptide

SKIN & AESTHETICS / COLOPHON

Contact the Editorial Desk

Correspondence on citations, corrections, and peer-reviewed additions to the research record — the most useful things a literature desk can receive.

Editorial correspondence

The almanac is glad to hear about the research record: a citation quoted inaccurately, a regulatory reference gone out of date, or a peer-reviewed study on GHK-Cu or the GLOW blend (or its BPC-157 or TB-500 components) that belongs on the references page. Corrections that sharpen the numbers are the most useful notes received, and each is read carefully.

The handiest messages name three things: the page in question, the exact passage or number at issue, and the supporting citation — a DOI or PubMed ID where possible — so a proposed change can be checked against the primary source before it is entered.

Editorial mailbox: editors@rejuvenationpeptide.com

Beyond the almanac

A few things fall outside what this site can address, so that no message goes unanswered for the wrong reason. Rejuvenation Peptide keeps a literature almanac — not a clinic, not a vendor — so it cannot:

  • Advise on, recommend, or comment on human use of any peptide discussed here, topical or injectable.
  • Suggest a dose, concentration, schedule, or route of administration for any individual.
  • Diagnose a condition or judge whether a specific research finding applies to a specific person.
  • Sell, source, recommend, or help locate any compound from any supplier.
  • Answer athlete anti-doping queries about the GLOW blend or its components, given that BPC-157 and TB-500 are prohibited in sport.

Readers seeking guidance on a health condition should consult a licensed clinician in their own jurisdiction. Replies to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.